GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 89 filers reported holding GALENA BIOPHARMA INC in Q1 2015. The put-call ratio across all filers is 0.55 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $1,468,000 | +1246.8% | 4,191,527 | +1697.0% | 0.00% | – |
Q2 2016 | $109,000 | +98.2% | 233,252 | +476.8% | 0.00% | – |
Q1 2016 | $55,000 | -3.5% | 40,440 | +3.7% | 0.00% | – |
Q4 2015 | $57,000 | -64.2% | 38,995 | -61.3% | 0.00% | – |
Q3 2015 | $159,000 | +15.2% | 100,698 | +23.8% | 0.00% | – |
Q2 2015 | $138,000 | -47.3% | 81,332 | -56.8% | 0.00% | – |
Q1 2015 | $262,000 | -34.0% | 188,183 | -28.4% | 0.00% | – |
Q4 2014 | $397,000 | -38.6% | 262,829 | -16.3% | 0.00% | – |
Q3 2014 | $647,000 | -52.2% | 314,105 | -29.0% | 0.00% | – |
Q2 2014 | $1,353,000 | +229.2% | 442,296 | +169.0% | 0.00% | – |
Q1 2014 | $411,000 | -41.4% | 164,411 | +16.3% | 0.00% | – |
Q4 2013 | $701,000 | +100.9% | 141,355 | -7.8% | 0.00% | – |
Q3 2013 | $349,000 | -57.6% | 153,283 | -58.7% | 0.00% | – |
Q2 2013 | $823,000 | +1859.5% | 370,828 | +1361.3% | 0.00% | – |
Q2 2012 | $42,000 | -48.8% | 25,376 | -31.2% | 0.00% | – |
Q1 2012 | $82,000 | – | 36,862 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 5,446,469 | $13,616,000 | 2.03% |
Harbour Capital Advisors, LLC | 78,450 | $196,000 | 0.19% |
SABBY MANAGEMENT, LLC | 708,089 | $1,770,000 | 0.10% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 174,600 | $437,000 | 0.07% |
Alyeska Investment Group, L.P. | 530,000 | $1,950,000 | 0.05% |
HIGHLAND CAPITAL MANAGEMENT LP | 528,027 | $1,320,000 | 0.05% |
KMS FINANCIAL SERVICES, INC | 118,042 | $295,000 | 0.05% |
Quantitative Investment Management, LLC | 348,500 | $871,000 | 0.04% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 538,100 | $1,345,000 | 0.04% |
DUMONT & BLAKE INVESTMENT ADVISORS LLC | 29,675 | $74,000 | 0.04% |